POTENT AND INTEGRIN SPECIFIC KGD-CONTAINING PLATELET ANTAGONISTS DESIGNED FROM THE GPIIB-IIIA SPECIFIC ANTAGONIST BARBOURIN

被引:0
|
作者
SCARBOROUGH, RM [1 ]
HSU, MA [1 ]
TENG, W [1 ]
ROSE, JW [1 ]
NANNIZZI, L [1 ]
CAMPBELL, AM [1 ]
CHARO, IF [1 ]
机构
[1] COR THERAPEUT INC,S SAN FRANCISCO,CA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:843 / 843
页数:1
相关论文
共 21 条
  • [1] BARBOURIN - A GPIIB-IIIA-SPECIFIC INTEGRIN ANTAGONIST FROM THE VENOM OF SISTRURUS-M-BARBOURI
    SCARBOROUGH, RM
    ROSE, JW
    HSU, MA
    PHILLIPS, DR
    FRIED, VA
    CAMPBELL, AM
    NANNIZZI, L
    CHARO, IF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (15) : 9359 - 9362
  • [2] A HUMANIZED ANTIBODY SPECIFIC FOR THE PLATELET INTEGRIN GPIIB/IIIA
    CO, MS
    YANO, S
    HSU, RK
    LANDOLFI, NF
    VASQUEZ, M
    COLE, M
    TSO, JT
    BRINGMAN, T
    LAIRD, W
    HUDSON, D
    KAWAMURA, K
    SUZUKI, K
    FURUICHI, K
    QUEEN, C
    MASUHO, Y
    JOURNAL OF IMMUNOLOGY, 1994, 152 (06): : 2968 - 2976
  • [3] CHARACTERIZATION OF A POTENT AND GPIIB-IIIA SPECIFIC PLATELET-AGGREGATION INHIBITOR FROM THE VENOM OF THE SOUTHEASTERN PYGMY RATTLESNAKE
    SCARBOROUGH, RM
    ROSE, JW
    HSU, MA
    FRIED, VA
    PHILLIPS, DR
    NANNIZZI, L
    CHARO, IF
    CIRCULATION, 1990, 82 (04) : 370 - 370
  • [4] CHARACTERIZATION OF A POTENT AND GPIIB-IIIA SPECIFIC PLATELET-AGGREGATION INHIBITOR FROM THE VENOM OF THE SOUTHEASTERN PYGMY RATTLESNAKE
    SCARBOROUGH, RM
    ROSE, JW
    HSU, MA
    FRIED, VA
    PHILLIPS, DR
    NANNIZZI, L
    CHARO, IF
    ARTERIOSCLEROSIS, 1990, 10 (05): : A898 - A898
  • [5] EF5077, A POTENT AND SPECIFIC NONPEPTIDE GPIIB/IIIA ANTAGONIST
    IIDA, H
    ASAI, K
    HATSUSHIBA, E
    ISHIKAWA, M
    ISHIZUKA, T
    KUROSAWA, T
    OHUCHI, S
    KATANO, K
    TSURUOKA, T
    OMOTO, S
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1315 - 1315
  • [6] Platelet glycoprotein IIb-IIIa receptor (GPIIb-IIIa) antagonists derived from amidinoindoles.
    Sall, DJ
    Arfsten, AE
    Berry, DR
    Denney, ML
    Harms, CS
    McCowan, JR
    Ray, JK
    Scarborough, RM
    Um, SL
    Utterback, BG
    Jakubowski, JA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (01) : 81 - 86
  • [7] A recombinant soluble form of the integrin αIIbβ3 (GPIIb-IIIa) assumes an active, ligand-binding conformation and is recognized by GPIIb-IIIa specific monoclonal, allo-, auto-, and drug-dependent platelet antibodies
    Peterson, JA
    Visentin, GP
    Newman, PJ
    Aster, RH
    BLOOD, 1998, 92 (06) : 2053 - 2063
  • [8] Dissociation of GPIIb-IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation.
    Frelinger, AL
    Furman, MI
    Krueger, LA
    Barnard, MR
    Michelson, AD
    BLOOD, 1999, 94 (10) : 21A - 21A
  • [9] DESIGN OF POTENT AND SPECIFIC INTEGRIN ANTAGONISTS - PEPTIDE ANTAGONISTS WITH HIGH SPECIFICITY FOR GLYCOPROTEIN-IIB-IIIA
    SCARBOROUGH, RM
    NAUGHTON, MA
    TENG, W
    ROSE, JW
    PHILLIPS, DR
    NANNIZZI, L
    ARFSTEN, A
    CAMPBELL, AM
    CHARO, IF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (02) : 1066 - 1073
  • [10] ALBOLABRIN AND ELEGANTIN 2 RGD-CONTAINING PEPTIDES FROM VIPER VENOMS WHICH BIND TO PLATELET GPIIB-IIIA
    WILLIAMS, JA
    RUCINSKI, B
    HOLT, J
    NIEWIAROWSKI, S
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 486 - 486